STAT
APRIL 2, 2025
Every doctor is a writer, or that’s what I used to believe. From the first days of medical school, my classmates and I learned how to write, albeit for a particular purpose and according to strict rules — a type of writing that wasn’t necessarily beautiful, or even particularly interesting. But it was writing.
PharmaVoice
APRIL 2, 2025
Amid widespread staff reductions at health agencies, a number of key officials have bid farewell to pharma’s top regulator.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
APRIL 2, 2025
Y ou’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday. Last week, NEJM AI published a study on a randomized clinical trial showing that a generative AI chatbot improved the symptoms of people with depression, anxiety, and eating disorders on par with gold-standard, human-administered therapy.
Express Pharma
APRIL 2, 2025
Rx Propellant, a life sciences infrastructure platform backed by Actis, has launched 1GV, a 136,000 sq. ft. research and innovation campus in Genome Valley, Hyderabad. The facility spans 1.8 acres and is designed to support the growth of Indias life sciences sector. 1GV is built on the site where the first construction in Genome Valley took place, marking the origins of one of Asias largest life sciences clusters.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
STAT
APRIL 2, 2025
Cell therapy veteran Arie Belldegrun is expanding his empire, bringing in two new managing directors at Vida Ventures after two founders left late last year. The VC firm announced Wednesday that it has hired longtime J.P. Morgan portfolio manager Matt Cohen and former MPM BioImpact partner Brian Goodman as managing directors. Cohen will steer public market investing — a first for the firm — while Goodman will work on creating and financing private startups.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
STAT
APRIL 2, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. What a day yesterday. Don’t miss all of the great coverage my colleagues produced, and keep an eye out for more today. I told you we don’t mess around on April Fools’ Day — nor on any other day, for that matter.
Express Pharma
APRIL 2, 2025
Algorithmic Biologics announced the appointment of Hiranjith GH as Chief Business Officer (CBO) to lead the companys commercial operations and its expansion globally, primarily in the US. With decades of experience in the pharmaceutical and life sciences industries, Hiran brings valuable expertise in go-to-market strategy for the US, business development, solution development, and cross-border team leadership.
STAT
APRIL 2, 2025
Dear Readers: Shortly after sunrise on Tuesday, STAT reporters around the county started their days with a deluge of alarmed, angry, and plaintive texts, emails, and even phone calls from employees across federal health agencies who just learned they had lost their jobs.
Express Pharma
APRIL 2, 2025
According to Tracxn’s latest report, funding in the pharma and healthcare sector has increased by 81.38 per cent to $79 million in March 2025, up from $43.5 million in February 2025. However, this marks a 50.06 per cent decline compared to the $158 million raised in March 2024. Late-stage funding accounted for the majority of investments, contributing $61.4 million, or 77.8 per cent of the total.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmafile
APRIL 2, 2025
The Ministry of Health, Labour and Welfare in Japan has authorised marketing and manufacturing of Dupixent (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in adults, whose disease is inadequately controlled by existing therapy. The approval in Japan was based on data from the BOREAS phase 3 study conducted by Sanofi and Regeneron. […] The post Dupixent approved as the first biologic medicine in Japan for COPD patients appeared first on Pharmafile.
Express Pharma
APRIL 2, 2025
DHL Group has acquired 100 per cent of CRYOPDP, a specialty courier serving clinical trials, biopharma, and cell and gene therapies. The acquisition is part of DHLs strategy to expand its life sciences and healthcare logistics capabilities. In parallel, DHL has entered a strategic partnership with Cryoport to enhance its supply chain services in the life sciences and healthcare sector.
Commonwealth Pharmacists Association
APRIL 2, 2025
Commonwealth Partnerships for Antimicrobial Stewardship 2.5 Announced Our award-winning collaborative antimicrobial stewardship programme has been extended for a further year. The Commonwealth Pharmacists Association (CPA) and Global Health Partnerships are delighted to announce the extension of our Commonwealth Partnerships for Antimicrobial Stewardship programme (CwPAMS).
Express Pharma
APRIL 2, 2025
Eris Lifesciences has designated Gopal Agrawal and Nita Borkar in leadership roles within its Domestic Branded Formulations business. Gopal Agrawal has joined as Vice President and will lead the Renal Care, Branded Injectables, and Market Access business segments. Prior to this role, he was Director of Market Access at Takeda. He has also worked with Shire Plc and Eli Lilly, bringing over three decades of experience in sales, market access, key account and tender management, pricing and reimburs
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Drug Patent Watch
APRIL 2, 2025
The Game-Changing Potential of Biosimilars in Population Health Management As healthcare professionals, we're constantly looking for innovative ways to improve patient outcomes and reduce costs. One area that's gaining significant attention is the use of biosimilars in population health management initiatives. But what exactly are biosimilars, and how can they make a meaningful impact on population health?
European Pharmaceutical Review
APRIL 2, 2025
The European Medicines Agency (EMA) has published a new draft reflection paper , which discusses reducing the quantity of clinical data needed for development and regulatory approval of biosimilars. This is part of the agencys work to improve the development and assessment of biosimilar medicines, while maintaining EU safety standards. EMA expects this will support better access to these treatments, as well as Europes position as an attractive developer in the market.
The Pharmacist
APRIL 2, 2025
NHS England (NHSE) has confirmed the funding allocated to each Additional Roles Reimbursement Scheme (ARRS) role for 2025/26, including pharmacists and pharmacy technicians. Primary care networks (PCNs) will be able to claim 66,972 per clinical pharmacist (Band 7-8a) working under the scheme, according to the latest contract. This is a 1.7% increase on the most […] The post New ARRS pharmacist funding confirmed by NHS England appeared first on The Pharmacist.
European Pharmaceutical Review
APRIL 2, 2025
You could be forgiven for thinking that the future is bright, that the future is artificial intelligence (AI). AI-driven clinical development could benefit industry to the tune of up to $25 billion, owing to smarter trials, better data, quicker results. 1 Most analysts think that AI will help cut down on timelines with AI-assisted clinical development estimated to take three to five years, versus the standard seven to nine years. 2 Lilly CEO David Ricks sees AI augmenting human productivity [and
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Pharmafile
APRIL 2, 2025
GRI Bio, a biotech company that specialises in treatment for inflammatory, fibrotic and autoimmune diseases, has announced that two global patents have been granted in Europe and Japan. The first is a European patent titled, Oxygenated Amino- or Ammonium Containing Sulfonic Acid, Phosphonic Acid and Carboxylic Acid Derivatives and Their Medical Use.
Drug Patent Watch
APRIL 2, 2025
The Future of Biopharma Intelligence: Why Direct Data Platforms are Revolutionizing the Industry As a biopharma professional, you're likely no stranger to the challenges of staying ahead in a rapidly evolving market. From navigating complex regulatory landscapes to keeping pace with the latest scientific breakthroughs, it's easy to get overwhelmed by the sheer volume of information at your fingertips.
Pharmafile
APRIL 2, 2025
ADHD coach John Harrington and breathwork facilitator Martin OToole will collaborate on ‘Breathwork for ADHD and Beyond’, a breathwork-orientated session for people with ADHD, and neurodivergent individuals more broadly. The two-hour session takes place on Sunday 13 April at We The Conscious studio in Hackney Downs, London, UK. In the first hour, Harrington will discuss […] The post ADHD coach and breathwork experts to run workshop for ADHD management appeared first on Pharmafi
Express Pharma
APRIL 2, 2025
Strides Pharma Science has been recognised in the S&P Global Sustainability Yearbook 2025, placing it among the top 10 percent of companies globally. The recognition highlights the companys Environmental, Social, and Governance (ESG) performance and commitment to sustainability. The S&P Global Sustainability Yearbook evaluates companies across industries based on ESG performance.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Pharmafile
APRIL 2, 2025
CluePoints has appointed Usama Dar as its new chief product and technology officer, effective 1 April 2025. This follows Dars leadership and development of product and R&D teams at the company. Dar has held leadership roles at organisations such as Westwing, Sciensus, Elsevier, The Guardian and Huawei. He has experience in eCommerce, software as a […] The post Usama Dar appointed as chief product and technology officer at CluePoints appeared first on Pharmafile.
Med Ed 101
APRIL 2, 2025
Sinemet, a key medication for managing Parkinsons disease, combines carbidopa and levodopa to improve motor symptoms such as tremors, stiffness, and slow movement. However, Sinemet is known for its potential drug interactions, which can affect its efficacy and lead to adverse effects. Understanding these interactions is essential for patients and healthcare providers to optimize treatment […] The post Sinemet Drug Interactions – Top 5 appeared first on Med Ed 101.
Express Pharma
APRIL 2, 2025
The American Gastroenterological Association (AGA) has recently released a major update to its clinical guideline for the pharmacological management of moderate-to-severe ulcerative colitis (UC). The new living guideline strongly recommends the early use of biologics and small-molecule therapies following 5-ASA failure, a significant departure from the traditional step-up approach.
The Pharmacist
APRIL 2, 2025
Pharmacists working in general practice and primary care networks are invited to take the latest survey from The Pharmacist. Please complete our survey. This survey of practice pharmacists working in the UK will cover cover a range of topics, including premises, assisted dying and morale. These are issues that are vital to the future of […] The post Practice and PCN pharmacists: Take our survey for a chance to win 200 appeared first on The Pharmacist.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Channels
APRIL 2, 2025
This week, Im rerunning some popular posts while I prepare for Fridays live video webinar: PBM Industry Update: Trends, Challenges, and Whats Ahead. Click here to see the original post from December 2024. Its time to pay attention to the money behind the 340B curtain. Minnesota just released the industrys first ever mandated financial report on the 340B Drug Pricing Program.
Pharma Times
APRIL 2, 2025
Advancing care for stage 3 or 4 Hodgkin lymphoma patients
Pharmaceutical Technology
APRIL 2, 2025
Amneal Pharmaceuticals, along with Shilpa Medicare, has launched the new presentation of bortezomib, Boruzu.
Expert insights. Personalized for you.
301 
Let's personalize your content